LukeRoy GeorgPikeMDDPhil

Assistant Attending / Assistant Professor

Overview of Dr. Pike

Dr. Luke Pike is a radiation oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Boston Children's Hospital. He received his medical degree from Yale School of Medicine and has been in practice 1 year. He is one of 8 doctors at Boston Children's Hospital and one of 106 doctors at Memorial Sloan Kettering Cancer Center who specialize in Radiation Oncology. He has more than 40 publications and over 500 citings.

Office
530 East 74th Street
New York, NY 10021
Book by Phone+1(702) 945-0844

Education & Training

Massachusetts General HospitalInternship, Preliminary Year, 2015 - 2016
Yale School of MedicineClass of 2015
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology

Certifications & Licensure

FL State Medical License 2023 - Present
NY State Medical License 2020 - 2026
NJ State Medical License 2020 - 2025
MA State Medical License 2015 - 2022
American Board of Radiology Radiation Oncology

Clinical Trials

A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain Start of enrollment: 2022 Jun 10
Recruiting
Phase 2
Roles: Principal Investigator, Contact

Publications & Presentations

PubMed

Advances in the Management of Lung Cancer Brain Metastases.
Kathryn G Hockemeyer, Chad G Rusthoven, Luke R G Pike
Cancers. 2024-11-09
2 citations
Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection.
Peter J Mazzone, Peter B Bach, Jacob Carey, Caitlin A Schonewolf, Katalin Bognar
Cancer Discovery. 2024-11-01
2 citations
Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases FromandOncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC).
Luke R G Pike, Emily Miao, Lillian A Boe, Tejas Patil, Brandon S Imber
Journal of Clinical Oncology. 2024-10-20

Lectures

The impact of race and socioeconomic status on outcomes for HPV-associated squamous cell carcinoma of the head and neck.
ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019

Press Mentions

Evaluating Stereotactic Radio Surgery plus TKI vs TKI Alone Among Patients with Brain Metastases from EGFR- and ALK-Altered NSCLC (Part II)September 18th, 2024
Evaluating Stereotactic Radio Surgery plus TKI vs TKI Alone Among Patients with Brain Metastases from EGFR- and ALK-Altered NSCLC (Part I)September 5th, 2024
MSK Research Highlights, August 13, 2024August 13th, 2024
Join now to see all